» Articles » PMID: 25756662

CXC Chemokines Function As a Rheostat for Hepatocyte Proliferation and Liver Regeneration

Overview
Journal PLoS One
Date 2015 Mar 11
PMID 25756662
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Our previous in vitro studies have demonstrated dose-dependent effects of CXCR2 ligands on hepatocyte cell death and proliferation. In the current study, we sought to determine if CXCR2 ligand concentration is responsible for the divergent effects of these mediators on liver regeneration after ischemia/reperfusion injury and partial hepatectomy.

Methods: Murine models of partial ischemia/reperfusion injury and hepatectomy were used to study the effect of CXCR2 ligands on liver regeneration.

Results: We found that hepatic expression of the CXCR2 ligands, macrophage inflammatory protein-2 (MIP-2) and keratinocyte-derived chemokine (KC), was significantly increased after both I/R injury and partial hepatectomy. However, expression of these ligands after I/R injury was 30-100-fold greater than after hepatectomy. Interestingly, the same pattern of expression was found in ischemic versus non-ischemic liver lobes following I/R injury with expression significantly greater in the ischemic liver lobes. In both systems, lower ligand expression was associated with increased hepatocyte proliferation and liver regeneration in a CXCR2-dependent fashion. To confirm that these effects were related to ligand concentration, we administered exogenous MIP-2 and KC to mice undergoing partial hepatectomy. Mice received a "high" dose that replicated serum levels found after I/R injury and a "low" dose that was similar to that found after hepatectomy. Mice receiving the "high" dose had reduced levels of hepatocyte proliferation and regeneration whereas the "low" dose promoted hepatocyte proliferation and regeneration.

Conclusions: Together, these data demonstrate that concentrations of CXC chemokines regulate the hepatic proliferative response and subsequent liver regeneration.

Citing Articles

The Role of microRNAs in Hepatocellular Cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance.

Tavakoli Pirzaman A, Alishah A, Babajani B, Ebrahimi P, Sheikhi S, Moosaei F Technol Cancer Res Treat. 2024; 23:15330338241239188.

PMID: 38634139 PMC: 11025440. DOI: 10.1177/15330338241239188.


Uncoupling hepatic insulin resistance - hepatic inflammation to improve insulin sensitivity and to prevent impaired metabolism-associated fatty liver disease in type 2 diabetes.

Niranjan S, Phillips B, Giannoukakis N Front Endocrinol (Lausanne). 2023; 14:1193373.

PMID: 37396181 PMC: 10313404. DOI: 10.3389/fendo.2023.1193373.


Molecular Mechanisms of Ischaemia-Reperfusion Injury and Regeneration in the Liver-Shock and Surgery-Associated Changes.

Pretzsch E, Niess H, Ben Khaled N, Bosch F, Guba M, Werner J Int J Mol Sci. 2022; 23(21).

PMID: 36361725 PMC: 9657004. DOI: 10.3390/ijms232112942.


Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonist.

Phillips B, Lantier L, Engman C, Garciafigueroa Y, Singhi A, Trucco M Cardiovasc Diabetol. 2022; 21(1):130.

PMID: 35831885 PMC: 9277870. DOI: 10.1186/s12933-022-01564-y.


Senescent hepatic stellate cells promote liver regeneration through IL-6 and ligands of CXCR2.

Cheng N, Kim K, Lau L JCI Insight. 2022; 7(14).

PMID: 35708907 PMC: 9431681. DOI: 10.1172/jci.insight.158207.


References
1.
Addison C, Daniel T, Burdick M, Liu H, Ehlert J, Xue Y . The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol. 2000; 165(9):5269-77. DOI: 10.4049/jimmunol.165.9.5269. View

2.
Ren X, Carpenter A, Hogaboam C, Colletti L . Mitogenic properties of endogenous and pharmacological doses of macrophage inflammatory protein-2 after 70% hepatectomy in the mouse. Am J Pathol. 2003; 163(2):563-70. PMC: 1868215. DOI: 10.1016/S0002-9440(10)63684-X. View

3.
Hebert C, Vitangcol R, Baker J . Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J Biol Chem. 1991; 266(28):18989-94. View

4.
Clark-Lewis I, DEWALD B, Geiser T, Moser B, Baggiolini M . Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proc Natl Acad Sci U S A. 1993; 90(8):3574-7. PMC: 46343. DOI: 10.1073/pnas.90.8.3574. View

5.
Block G, Locker J, BOWEN W, Petersen B, Katyal S, Strom S . Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium. J Cell Biol. 1996; 132(6):1133-49. PMC: 2120765. DOI: 10.1083/jcb.132.6.1133. View